In medical news:

The American Health Association and several other medical societies issued recommendations from a recent drug shortage summit. They include urging the FDA to share more information to help health care providers and manufacturers prepare for shortages. Other high-priority recommendations include conducting a Government Accountability Office study to identify new and emerging factors that contribute to shortages; developing a list of critical drugs essential for emergency response and preserving life; and offering incentives to manufacturers that create contingency production plans for pharmaceuticals on the critical drug list.

Read more here.

Leave a Comment

Your email address will not be published.